Skip to content

E-MAIL US:info@curegp.org

Sign In / Register

0 items - $0.00 Checkout

Home
About Us
About Gastroparesis
Faces of GP
Events
- GASTROPARESIS AWARENESS MONTH 2022 GIVEAWAY 2!
Resources
- Videos
  - What Reasearchers Should Know About Gastroparesis
  - Interviews
    - Ask an Expert
    - Ostomies
- Blogs
Campaigns
Store
- View My Cart
- My Account

Gastroparesis: Fighting For Change > Events > Support

Loading view.

Support

Events
Support

Events Search and Views Navigation

Enter Keyword. Search for Events by Keyword.

Event Views Navigation

List
Month

Select date.

5:30 pm

February 11, 2020 @ 5:30 pm - 6:30 pm EST

Gastroparesis Support Group by Northwestern Medicine

Telephone Meeting

Classes, Events and Support Groups Northwestern Medicine offers a wide range of classes, events and support groups throughout the year - in your local community - to help you live Read More

Next Day

Google Calendar
iCalendar
Outlook 365
Outlook Live
Export .ics file
Export Outlook .ics file

Login

Username or Email Address *

Password *

Remember me

Don't have an account? Signup Now »
Lost your password?

Language

Recent Posts

GASTROPARESIS AWARENESS MONTH 2023 GIVEAWAY !
Gastroparesis 2023 Awareness Campaign – #GPFullLife4Me
GASTROPARESIS AWARENESS MONTH 2022 GIVEAWAY 2!
GASTROPARESIS AWARENESS MONTH 2022 GIVEAWAY!
Kelly Sharp

Social Media Feed

Gastroparesis: Fighting for Change
updated their status.

04/23/26

This content isn’t available right now

When this happens, it’s usually because the owner only shared it with a small group of people, changed who can see it or it’s been deleted.

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/20/26

The #Gastroparesis community respectfully requests the attention of the U.S. Food and Drug Administration. We have one FDA-approved medication (Metoclopramide/Reglan/Gimoti). There have been no novel drugs approved in more than 40 years. The Expanded Access Program for Domperidone ended last year, denying access to one of the few medication alternatives available. We are a community in crisis, and we need consistently safe, reliable, effective treatments and cures. #CureGP
… See MoreSee Less

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/18/26

Not much information on this yet, but we will try to follow its progress.
… See MoreSee Less

www.bioworld.com

www.bioworld.com

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/18/26

finance.yahoo.com/sectors/healthcare/articles/dr-falk-pharma-renexxion-announce-120000503.html
… See MoreSee Less

Dr. Falk Pharma and Renexxion Announce Late-Breaker Oral Presentation of Global Phase 2b Gastroparesis Results at Digestive Disease Week (DDW) 2026

finance.yahoo.com

FREIBURG, Germany and ROSCREA, Ireland, April 16, 2026 (GLOBE NEWSWIRE) — Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic…

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/13/26

Looks like the first date is actually April 15, and not March 15.
… See MoreSee Less

This content isn’t available right now

When this happens, it’s usually because the owner only shared it with a small group of people, changed who can see it or it’s been deleted.

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/12/26

Plain Language Summary: "This case report describes a 65-year-old man with idiopathic gastroparesis who underwent gastric peroral endoscopic myotomy (G-POEM) combined with simultaneous transpyloric stenting. The procedure led to complete symptom resolution and normalization of the Gastroparesis Cardinal Symptom Index, with sustained long-term relief. The authors note that there are currently no data on using these 2 endoscopic techniques together. They hypothesize that transpyloric stenting may modify the healing process after myotomy by preventing fibrosis and restenosis of the gastric outlet, potentially increasing the efficacy and long-term durability of G-POEM in treating gastroparesis."journals.lww.com/acgcr/fulltext/2026/04000/efficacy_of_combined_gastric_peroral_endoscopic.22.aspx#Gastroparesis #CureGP
… See MoreSee Less

Efficacy of Combined Gastric Peroral Endoscopic Myotomy and … : ACG Case Reports Journal

journals.lww.com

ly no data on the concurrent use of these 2 endoscopic techniques. Through this case, we postulate that transpyloric stenting alters the natural healing of the myotomy, preventing fibrosis and resteno…

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/10/26

Medical Gaslighting in Gastroenterology: www.ghadvances.org/article/S2772-5723(26)00082-8/fulltextFull Text PDF: www.ghadvances.org/article/S2772-5723(26)00082-8/pdf#gastroparesis #CureGP #IBS #FD #DGBI
… See MoreSee Less

www.ghadvances.org

www.ghadvances.org

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/06/26

www.altitudesmagazine.com/fda-updates-glp-1-drug-safety-labels-after-gastroparesis-reports-surge/
… See MoreSee Less

FDA Updates GLP-1 Drug Safety Labels After Gastroparesis Reports Surge Among Long-Term Users – Altitudes Magazine

www.altitudesmagazine.com

With approximately 40 million Americans currently prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist — a figure that has more than doubled since

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/05/26

"In conclusion, our study suggests that pyloric FLIP plays a role in differentiating patients that may benefit from targeted pyloric therapies. It will be critical for multicenter collaboration and standardization of procedural technique and symptom assessment to reach an evidence-based understanding of the role of the pylorus in chronic nausea, vomiting, and abdominal pain in pediatrics to establish the most suitable treatments."onlinelibrary.wiley.com/doi/10.1111/nmo.70303#Gastroparesis #CureGP
… See MoreSee Less

Pyloric Metrics and Distensibility Plateau by Functional Luminal Imaging Probe in Pediatric Patients: A Pilot Study

onlinelibrary.wiley.com

Pediatric patients underwent pyloric functional luminal imaging probe (FLIP) for refractory upper gastrointestinal symptoms. Unlike prior adult studies, pyloric distensibility did not correlate to ga….

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Gastroparesis: Fighting for Change

04/05/26

View on Facebook

·
Share

Share on Facebook

Share on Twitter

Share on Linked In

Share by Email

Copyright by Gastroparesis: Fighting For Change, LLC in 2019

P.O. Box 712, Morrisville, PA 19067

Home
Privacy Policy